MedPageToday
MedPage Today) — Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an imbalance in deaths among patients taking the drug.
“The overall benefit of the drug no longer outweighs…
Read More
Sickle Cell Disease Drug Pulled From Global Markets
Lloyd Mischke
17:29
MedPage Today) — Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an imbalance in deaths among patients taking the drug. “The overall benefit of the drug no longer outweighs…
